# Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)

> **NCT06141837** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 51 (actual)

## Conditions studied

- Pseudomonas Aeruginosa
- COVID-19

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT06141837
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-04-20
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06141837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06141837, "Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06141837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*